Forum rules
- Comments must be civil and on topic
- Back up claims with evidence/reasoning/sources (posting links is allowed)
- No commercials/harassment/spam
Post Reply
Posts: 351
Joined: Fri Jul 20, 2018 5:13 pm


Post by biopearl123 » Sat May 30, 2020 12:55 am

The MDS oral presentation says it it embargoed until the meeting, yet we have access to the abstract. So what is embargoed? I suspect it is the MDS bone marrow data. What if bone marrow is normalizing in the TI patients? We have seen suggestions in the past but this could be the research bombshell Geron is waiting to drop at the meetings. We shall see. There is already an poster re MF fibrosis regression in the MF R/R population. We will hear more about how Lus does not show the durability of Imet and treats only a fraction of the overall MDS population. The targeted Imet treatment population is also sicker with a higher TR. So far the findings in both MF and MDS are not seen anywhere else. The stock is in the basement. Someone needs to turn on the light. bp

Posts: 38
Joined: Sat Sep 28, 2019 10:00 pm

Re: embargo?

Post by rccola335 » Sat May 30, 2020 3:48 pm

i would think if that was case they would of waited to sell the shares until after the EHA - would be nice tho

Post Reply